抗体调理
单克隆抗体
巨噬细胞
吞噬作用
生物
调理素
癌症研究
封锁
抗体
癌症免疫疗法
CD47型
免疫疗法
癌细胞
免疫学
细胞生物学
化学
单核吞噬细胞系统
单克隆
癌症
吞噬细胞
细胞因子
脾脏
内生
免疫系统
受体
作者
Lawrence J. Dooling,Jason C. Andrechak,Brandon H. Hayes,Siddhant Kadu,William Zhang,Ruby Pan,Manasvita Vashisth,Jerome Irianto,Cory Alvey,Leyuan Ma,Dennis E. Discher
标识
DOI:10.1038/s41551-023-01031-3
摘要
In solid tumours, the abundance of macrophages is typically associated with a poor prognosis. However, macrophage clusters in tumour-cell nests have been associated with survival in some tumour types. Here, by using tumour organoids comprising macrophages and cancer cells opsonized via a monoclonal antibody, we show that highly ordered clusters of macrophages cooperatively phagocytose cancer cells to suppress tumour growth. In mice with poorly immunogenic tumours, the systemic delivery of macrophages with signal-regulatory protein alpha (SIRPα) genetically knocked out or else with blockade of the CD47–SIRPα macrophage checkpoint was combined with the monoclonal antibody and subsequently triggered the production of endogenous tumour-opsonizing immunoglobulin G, substantially increased the survival of the animals and helped confer durable protection from tumour re-challenge and metastasis. Maximizing phagocytic potency by increasing macrophage numbers, by tumour-cell opsonization and by disrupting the phagocytic checkpoint CD47–SIRPα may lead to durable anti-tumour responses in solid cancers. Durable anti-tumour responses can be triggered by maximizing the cooperative phagocytic potency of macrophages through the disruption of the CD47–SIRPα macrophage checkpoint and by delivering a tumour-opsonizing monoclonal antibody.
科研通智能强力驱动
Strongly Powered by AbleSci AI